Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis-Reference-Cited by-同舟云学术

Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis

Published:2016-01 Issue:1 Volume:15 Page:318-328
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Borràs Eva,Cantó Ester,Choi Meena,Maria Villar Luisa,Álvarez-Cermeño José Carlos,Chiva Cristina,Montalban Xavier,Vitek Olga,Comabella Manuel,Sabidó Eduard

Funder

Ministerio de Ciencia e Innovacion

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference44 articles.

1. Immunology of multiple sclerosis;Sospedra;Annu. Rev. Immunol,2005

2. Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis;Miller;Lancet Neurol,2005

3. Disability and T2 MRI lesions: A 20-year follow-up of patients with relapse onset of multiple sclerosis;Fisniku;Brain,2008

4. Baseline MRI predicts future attacks and disability in clinically isolated syndromes;Tintoré;Neurology,2006

5. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?;Tintoré;Neurology,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Non-Targeted Lipidomic-Based Classifier Reveals Two Candidate Biomarkers for Ischemic Stroke in Hypertensive Individuals;Risk Management and Healthcare Policy;2024-07

2. Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis;Clinical Proteomics;2024-06-16

3. Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis;Cochrane Database of Systematic Reviews;2023-09-08

4. Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges;Journal of Clinical Medicine;2023-06-26

5. A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management;Journal of Translational Medicine;2022-12-21